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Abstract
Cellular receptors can act as molecular switches, regulating the sensitivity of microbial proteins to conformational changes
that promote cellular entry. The activities of these receptor-based switches are only partially understood. In this paper, we
sought to understand the mechanism that underlies the activity of the ANTXR2 anthrax toxin receptor-based switch that
binds to domains 2 and 4 of the protective antigen (PA) toxin subunit. Receptor-binding restricts structural changes within
the heptameric PA prepore that are required for pore conversion to an acidic endosomal compartment. The transfer cross-
saturation (TCS) NMR approach was used to monitor changes in the heptameric PA-receptor contacts at different steps
during prepore-to-pore conversion. These studies demonstrated that receptor contact with PA domain 2 is weakened prior
to pore conversion, defining a novel intermediate in this pathway. Importantly, ANTXR2 remained bound to PA domain 4
following pore conversion, suggesting that the bound receptor might influence the structure and/or function of the newly
formed pore. These studies provide new insights into the function of a receptor-based molecular switch that controls
anthrax toxin entry into cells.
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Introduction
Cellular receptors can act as molecular switches that initiate
conformational changes in microbial proteins required for cellular
entry. Examples of such switches include an anthrax toxin receptor
(described in detail below) as well as those for a number of viruses
including HIV-1 and other retroviruses [1,2,3], measles virus [4],
and herpesviruses [5]. The mechanisms by which these receptor-
based switches function to promote cellular entry are only partially
understood. In this report we set out to define the mechanism by
which a receptor-based switch regulates anthrax toxin prepore-to-
pore conversion.
Anthrax toxin, the key virulence factor secreted by Bacillus
anthracis, is a bacterial AB toxin composed of three independent,
plasmid-encoded polypeptide chains: the receptor-binding (B)
moiety, protective antigen (PA), and two different enzymatic (A)
moieties, lethal factor (LF) and edema factor (EF) [6,7,8]. The first
step in cellular intoxication involves binding of an 83 kD form of
PA (PA83) to specific cell surface receptors. Although several PA
receptors have been defined [9,10,11], anthrax toxin receptor type
2 (ANTXR2) (also known as capillary morphogenesis protein 2;
CMG2), is the most physiologically relevant receptor [12,13,14].
ANTXR2 is a type 1 transmembrane protein and its extracellular
von Willebrand factor type A (VWA) domain is the site of PA-
binding [15,16]. Following receptor binding, PA83 is cleaved to a
63kD form (PA63) that spontaneously oligomerizes to form either a
heptameric, or an octameric, PA63 prepore structure [17,18].
Oligomeric PA63-receptor complexes are then taken into cells
primarily by a clathrin-dependent endocytic mechanism and
delivered to an acidic endosomal compartment where low pH
triggers formation of a PA63 pore within an endosomal membrane
[19,20]. LF and EF are then translocated through the pore and
delivered to the cytosol where they promote intoxication [21].
X-ray structural analysis of monomeric and heptameric PA-
ANTXR2 VWA-domain complexes revealed that the receptor
acts as a molecular switch or clamp that inhibits prepore-to-pore
conversion at neutral pH [15,16]. Specifically, the receptor VWA-
domain interacts with the base regions of PA domains 2 and 4,
thereby sterically hindering the movement of the PA 2b3-2b4 loop
region necessary for pore formation [15,16]. Those findings led to
a model in which release of the receptor contact with PA domain 2
at an acidic endosomal pH is necessary to permit the
conformational changes required for PA pore formation [15,16].
Consistent with this idea, the pH threshold of the receptor-
regulated toxin pore formation can be dictated by specific amino
acid residues located at the PA domain 2-binding region of the
ANTXR2 VWA-domain [22].
Presently, it is not clear if PA domain 2-receptor contacts are
released at a step that occurs prior to, or is coincident with,
prepore-to-pore conversion. Furthermore, it is not clear if the
receptor remains attached following pore conversion and, if so,
how it remains attached. Evidence supporting dissociation has
come from co-immunoprecipitation experiments [23] and from
previous NMR studies [24,25]. On the other hand, evidence in
favor of receptor attachment has come from other co-immuno-
precipitation studies [19,26], from NMR binding studies per-
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T A     formed with a fragment (Domain 4) of PA [27], and from the
finding that the presence of a receptor seems to influence voltage-
dependent inactivation and small molecule inhibition properties of
the newly formed pore [28]. Based upon structural considerations,
it has also been argued that the receptor may remain bound to
serve as a structural support for the pore [16,29].
To clarify these issues, we have employed NMR techniques to
monitor changes in the PA63 heptamer-ANTXR2 VWA domain
contacts as a function of pH. Initially we attempted to examine the
interaction between the ANTXR2 VWA domain and PA63 using
chemical shift perturbation (CSP) by titrating in substoichiometric
amounts of unlabeled PA63 into a
1H-
15N labeled ANTXR2
sample. Based on results with other systems [30], we anticipated
that titrating in PA63 might allow us to monitor chemical shift
changes as a function of receptor binding and/or cause selective
broadening of specific peaks associated with residues at the PA
binding interface. If so, this would allow us to monitor specific
receptor residues bound to PA63 under different pH conditions.
Additionally, if shift perturbation of crosspeaks were detected using
saturating conditions of the binding partner (PA63), this would help
to approximate the fractional population of bound species versus
the free species at equilibrium [30]. However, when low
stoichiometric concentrations of PA63 were titrated into the
ANTXR2-VWA domain sample, extensive line broadening and
the disappearance of cross-peaks in the
1H-
15N TROSY-HSQC
was observed at a ratio of 1:0.25 ANTXR2-VWA domain to PA63.
This was likely due to the large size of the PA complex, indicating
a larger effective correlation time (tc), restricted local motion, and
complete binding at the concentrations used. Therefore, we
hypothesized that the method of transferred cross-saturation
(TCS) may be well suited to investigate these interactions since
this approach has previously been used to identify contact residues
of protein ligands in large protein complexes [31].
To investigate the function of the ANTXR2-based switch, TCS
was employed to monitor changes that occur in PA63 heptamer-
ANTXR2 VWA-domain contacts as a function of pH. In this
approach, an unlabeled protein is added at substoichiometric
amounts to a deuterated,
15N-labeled protein, in this case, PA63
and the ANTXR2 VWA-domain, respectively. The aliphatic
proton resonances of the unlabeled protein are then saturated with
a brief radiofrequency pulse and this saturation is transferred
selectively to contact residues of the
2H,
15N-labeled protein by
spin diffusion. Consequently, the intensity of amide cross-peaks
representing labeled residues that lie at the protein-protein
interaction surface are selectively reduced by cross-relaxation
[32,33]. Here we have used this technique to obtain evidence for a
new toxin-receptor intermediate in the pathway leading to pore
formation and show that the receptor remains attached to PA
domain 4 following low pH-dependent conversion. Additionally,
chemical shift perturbations associated with receptor residues
located near the PA domain 4 binding region revealed moderate
conformational changes that occur during the attachment and






15N-labeled ANTXR2 VWA-domain was
produced as a GST-fusion protein from bacterial cells. In order
to limit spin diffusion in the
15N-labeled protein, it was extensively
deuterated by growing the cells in 100% D2O minimal media
using
2H-glucose as the sole carbon source [32]. The labeled
VWA-domain was purified to homogeneity as described under
Materials and Methods and was unfolded to protonate the residues
within the protein core and refolded to increase the number of
cross-peaks in the [
15N,
1H] TROSY-HSQC spectrum. The
integrity of the refolded protein was confirmed by circular
dichroism (CD) analysis performed at either pH 8.0, 6.0, or 5.0
and in each case the protein displayed alpha-helical properties
(Supplementary Figure S1). The refolded protein also functioned
as an efficient receptor decoy in a toxin neutralization assay
(Supplementary Figure S2). Moreover, Transverse Relaxation
Optimized Spectroscopy-Heteronuclear Single-Quantum Coher-
ence (TROSY-HSQC) spectrum analysis indicated that the
protein was correctly refolded when compared to a control [
15N,
1H] TROSY-HSQC spectrum of the ANTXR2 VWA domain
that had not been previously denatured (Figure 1A). Assignments
for the backbone resonances of the ANTXR2 VWA-domain were
obtained using data from the following experiments: [
1H-
15N]
TROSY-HSQC, 3D TROSY-HNCO, 3D TROSY-HN(CA)CO,
3D TROSY-HNCACB, 3D TROSY-HNCA, and a 3D
15N-
edited NOESY-HSQC. NMR data were processed using
NMRPipe and analyzed using Sparky and CARA software
packages [34,35,36]. A representative example of this data analysis
is shown in Supplementary Figure S3. Using this approach 87% of
the backbone residues of the ANTXR2 VWA-domain, including
the PA contact residues, were assigned (Figure 1A and B).
ANTXR2 residues that contact PA domains 2 and 4 are
saturated by transferred cross saturation (TCS)
The principle of the TCS approach used to monitor PA63-
ANTXR2 VWA-domain interactions is outlined in Figure 2A. In
order to observe saturation transfer, the concentration of the
binding partner must be kept sufficiently low to effectively allow
for fast exchange so that amide cross-peaks are not broadened
following its addition. The efficiency of TCS depends on the
sample conditions as well as the binding constants between the
receptor and PA. According to Shimada et al, TCS is applicable
for a system where a large pB, or fraction of bound ligands is
preferred for high saturation efficiency, if koff .0.1 s
21,o ri fk off
$10 s
21,ap B $0.1 is preferred [37]. Therefore, for the TCS
experiments, the concentrations of the two protein partners were
optimized by performing titration experiments at pH 8.0, and a
Author Summary
The bacterium that causes anthrax produces a toxin called
anthrax toxin that is largely responsible for causing disease
symptoms. The first step in anthrax intoxication involves
binding of the toxin to a specific protein, called a receptor,
on the cell surface. Receptor-binding acts like a switch to
prevent the toxin from forming a pore in a cell membrane
until the toxin-receptor complex is taken up into cells and
delivered to a specific location (called an endosome)
where it is exposed to an ‘‘acid bath’’. This acidic
environment promotes structural changes in the toxin
leading to pore formation in the endosomal membrane. In
this report, we have studied how the receptor regulates
pore formation by following the associated changes in
toxin-receptor contacts. These studies have defined a new
toxin-receptor intermediate in the pathway leading to
pore conversion and demonstrate that the receptor
remains bound after pore conversion. Our results provide
important new insights into how the receptor regulates
anthrax toxin pore formation, information that could be
useful for designing new therapeutic strategies to treat
this disease.
ANTXR2 Controls Toxin Pore Formation
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chosen for all cross saturation experiments, because at this
concentration there were no signs of peak broadening. Three
separate sets of interleaved experiments were subsequently
performed on the ANTXR2 VWA: (PA63)7 complex in buffers
of pH 8.0, 6.0, and 5.0. Saturation transfer was achieved by
applying a selective radiofrequency pulse at 0.8 ppm, prior to the
[
15N,
1H] TROSY-HSQC. A pH of 8.0 was chosen for the initial
analysis because it closely approximated those used previously for
X-ray structural analysis of PA-receptor complexes. i.e. pH 7.5
[16] and pH 8.25, [15]. These studies revealed that the majority of
the labeled residues in the ANTXR2 VWA-domain were not
saturated by a radiofrequency pulse, i.e. those with similar signal
intensities under conditions of no saturation (black peaks) or
saturation (red peaks) (Figure 2B). However, a subset of the amide
cross-peaks were saturated (black-only peaks) in the overlayed
spectra (Figure 2B) and a number of those cross-peaks corre-
sponded to contact residues with PA domains 2 or 4. For simplicity
the saturation data was represented as 1D cross sections of the
corresponding cross-peaks in the HSQC spectra (Figure 3A). The
degree of saturation of each residue was calculated by dividing the
observed peak intensity of the saturated spectrum (Is) by the
observed peak intensity of the control spectrum (Io) (unsaturated).
In these studies an (Is/Io) value of ,0.75 is considered significant
and one of ,0.5 highly significant, as in [37]. Based upon these
criteria all of the PA domain 2 and 4 contact residues that could be
unambiguously assigned were saturated under these conditions
(Figure 3B). Taken together, this study verified that the TCS
method can be used to specifically monitor contacts between the
ANTXR2 VWA-domain and PA domains 2 and 4 in the
heptameric toxin-receptor complex.
Identification of a new toxin-receptor complex
intermediate at pH 6.0
To characterize the changes in PA-receptor contacts that
occur after incubating the complex under mildly acidic
Figure 1. A)
1H-
15N TROSY-HSQC of the ANTXR2 VWA domain. Cross-peaks with labeled assignments represent receptor residues at the PA
domain 2 and domain 4 interaction surfaces. B) The crystal structure of the interface between monomeric PA83 bound to ANTXR2 (PDB 1T6B; Protein
Data Bank), showing the base regions of domain 2 and 4 of PA. Representative PA contact residues of ANTXR2 are indicated: domain 2 contact sites
are in hot pink and domain 4 contacts are in cyan. All images were generated using PymolX11 (DeLano Scientific, San Carlos, CA).
doi:10.1371/journal.ppat.1002354.g001
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condition is approximately 1.0 pH unit above that needed to
trigger toxin prepore to pore conversion when the PA heptamer
is bound to the ANTXR2 VWA-domain [23,28] (Supplementary
Figure S4). However, not all of the PA-contact residues that were
observed at pH 8 were visible in the saturated and unsaturated
spectra obtained at pH 6. This finding is probably due to a
structural change upon loss of contact with the PA yielding to an
increased H/D exchange or/and slow conformational exchange
dynamics.
Analysis of the data clearly showed that the PA domain 4
contact residues that were resolved remained strongly saturated at
pH 6 (residues G53, S54, N57, V115, E117, T118, H121, E122,
and G123; (Figure 4A and 4B). By striking contrast, PA domain 2
contact residues were much less saturated at pH 6.0 (Figure 4B).
Taken together, these data are consistent with a model in which
the receptor remains bound to PA domain 4 but its interactions
with PA domain 2 are significantly weakened or are lost prior to
prepore-to-pore conversion.
The ANTXR2 VWA-domain remains attached to PA
domain 4 following prepore-to-pore conversion
When bound to ANTXR2, the PA63 prepore is triggered to
form a pore species at pH values that are less than or equal to
pH 5.2 [23,28] (Supplementary Figure S4). Therefore, to
determine if the receptor remains attached to PA following pore
formation, the TCS experiment was performed under both
saturating and non-saturating conditions at pH 5.1. Consistent
with the results obtained at pH 6.0, the receptor residues that
contact PA domain 2 were not saturated at pH 5.1, with the
possible exception of residue A159 (Figure 5A and 5B). More
importantly however, virtually all of the domain 4 contact residues
that could be resolved at this pH value were saturated at pH 5.1
(Figure 5B). These data are consistent with a model in which the
receptor contacts with PA domain 2 are lost during anthrax toxin




15N] TROSY-HSQC data also revealed chemical shift
perturbations of certain receptor residues, including PA domain 4
contact-residues that were associated with (PA63)7 binding at
pH 8.0 (Figure 6A). Small shift changes due to the isotope effect of
being a highly deuterated protein were also taken into consider-
ation as well as the pH effects [38]. Specifically, peaks associated
with residues in and around helix 1 of the ANTXR2 VWA
domain, that were involved in binding PA domain 4, significantly
changed their position in the presence of PA63. These residues
include G53, W59, and N57 (Figure 6B). A similar observation
was made with residues Y46 and F47, which lie within the
hydrophobic core of the ANTXR2 VWA domain, as well as with
G135, which lies on the opposite face of the receptor VWA
domain (Figure 6B). These latter effects are likely due to an
allosteric or structural change in the receptor domain following PA
binding. Strikingly, the peaks associated with all of these residues
reverted back to their ‘‘unbound’’ configuration when the
ANTXR2 VWA/PA63 complex was incubated at pH 5.1
(Figure 6A), even though the receptor remains bound to PA
domain 4 under this condition. The only exception was residue
Y46 which was not resolved at pH 5.1 but moved back towards its
‘‘unbound’’ configuration at pH 6, (Figure 6A).
Discussion
In this study we have used the TCS NMR approach to monitor
how the ANTXR2-based receptor switch regulates anthrax toxin
prepore-to-pore conversion. We showed that this is a robust
method for identifying the receptor contacts with PA domains 2
and 4, in the prepore configuration at pH 8.0. We also obtained
evidence at pH 6.0 for a new toxin-receptor intermediate in the
pathway leading to pore formation, one in which the receptor
remains bound to PA domain 4 but contacts with PA domain 2
have been significantly weakened. That intermediate would
presumably exist within a mildly acidic early endosomal
compartment during endocytic trafficking of toxin-receptor
complexes [39]. Furthermore, we demonstrated that the
ANTXR2 VWA-domain remains attached to PA domain 4 after
triggering PA pore formation at pH 5.1, consistent with a more
strongly acidic late endosomal pH [39]. Subtle structural changes,
associated with reversion back to an unbound configuration, were
also detected in residues located near the PA domain 4-binding
site following pore conversion. This effect was also seen in the
opposite face of the protein with residue G135, and with two
hydrophobic residues within the core, Y46 and F47. It is known
that chemical shifts of those nuclei that lie within close proximity
of the binding partner can be substantially perturbed in the
presence of that partner. However chemical shift perturbations
(CSP) can also arise from allosteric effects as well as extended
conformational changes that may occur in the target protein upon
protein partner binding [40,41]. These latter effects most likely
account for the chemical shift perturbations seen with residues
Y46, F47, and G135, which lie distal from the PA63 binding site of
the receptor (Figure 6B). Taken together, these studies have led to
a revised model of the changes in toxin-receptor contacts during
pore formation (Figure 7) and support the idea that the bound
receptor may influence the structural and/or functional properties
of the toxin pore.
It is unlikely that the TCS effects that were observed could be
attributed to non-specific aggregation of the PA63 heptamer-
receptor complex at the different pH values tested since these
effects were almost exclusively restricted to the toxin-binding face
of the receptor. Indeed, inspection of 1D slices of the TCS
experiments for selected crosspeaks did not indicate a broadening
of lineshapes at several residues at pH 8 or pH 5, as would have be
expected if there was aggregation (data not shown). Additionally,
to further assess protein aggregation at pH 8 and pH 5, a
wavelength scan (from 280–360 nm) was performed on the
ANTXR2 VWA domain in complex with PA63 at the same 10:1
ratio used for the TCS NMR experiments, since protein
aggregation can be monitored at 340 nm [42,43]. These studies
revealed no substantial increase of absorbance at 340 nm between
pH 8 and pH 5 (Supplementary Table S1), and visual inspection
of the sample yielded no noticeable turbidity in the supernatant,
under any of the conditions tested. Furthermore, there was no
Figure 2. The principle of Transferred Cross Saturation (TCS) applied to the (PA63)7-ANTXR2 complex. A) Schematic of TCS between
ANTXR2 VWA domain and the PA63 pore.
2H
15N-labeled ANTXR2 VWA-domain was mixed at a ratio of (10:1) with PA63 heptamer. Radiofrequency
pulses were applied to the sample, in order to saturate the aliphatic protons of the PA63 heptamer. Saturation is then transferred to the contact
residues of the labeled ANTXR2 VWA-domain, reducing the intensity of the corresponding cross peaks in the spectrum. B) Saturated and unsaturated
spectra of the (PA63)7-ANTXR2 complex at pH 8.0. The [
1H,
15N] TROSY-HSQC spectra of the
2H-
15N labeled ANTXR2-VWA domain complexed with the
PA63 heptameric prepore are shown overlayed under saturating or non-saturating (black) conditions.
doi:10.1371/journal.ppat.1002354.g002
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the pH 8.0 or pH 5.0 samples before or after a 24 hour incubation
at 37uC (Supplementary Table S2). Therefore, we concluded that
the TCS NMR studies were not compromised by any non-specific
aggregation of the PA63 heptamer-receptor complex at pH values
ranging from pH 5–8.
Figure 3. The receptor contact residues with PA domain 2 and 4 that are saturated at pH 8.0. A) A subset of the 1D slices of the [
15N,
1H]
TROSY-HSQC spectra obtained at pH 8.0 highlighting several cross-peaks without saturation at pH 8 (left panels) or with saturation at pH 8 (right
panels). Cross-peaks representing PA domain 2 and 4 contact residues are indicated with red and blue labels, respectively. B) A plot of the intensity
ratio (Is/Io) of the transferred cross saturation of (PA63)7 and the interacting residues on the ANTXR2 VWA domain. Significant cross saturation (Is/
Io#0.75) is indicated with a single asterisk, and highly significant (Is/Io#0.5) is indicated with a double asterisk. The errors were calculated by
propagating the base-plane noise, which was derived from the signal-to-noise ratios of both control and the saturated spectra and this value was
averaged from two duplicate experiments.
doi:10.1371/journal.ppat.1002354.g003
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15N,
1H] TROSY-HSQC spectra
obtained at pH 6.0 highlighting several cross-peaks without saturation at pH 6 (left panels) or with saturation at pH 6 (right panels). Cross-peaks
representing PA domain 2 and 4 contact residues are indicated with red and blue labels, respectively. B) A plot of the intensity ratio (Is/Io) from the
transferred cross saturation of (PA63)7 heptamer to interacting residues on the ANTXR2 VWA-domain. Significant cross saturation (Is/Io#0.75) is
indicated with a single asterisk, and highly significant (Is/Io#0.5) is indicated with a double asterisk. The errors were calculated by propagating the
base-plane noise, which was derived from the signal-to-noise ratios of both control and the saturated spectra and this value was averaged from two
duplicate experiments.
doi:10.1371/journal.ppat.1002354.g004
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15N,
1H] TROSY-HSQC spectra highlighting
several cross-peaks without saturation at pH 5.1 (left panels) or with saturation at pH 5.1 (right panels). Cross-peaks representing PA domain 2 and 4
contact residues are indicated with red and blue labels, respectively. B) A plot of the intensity ratio (Is/Io) from the transferred cross saturation of
(PA63)7 to interacting residues on the ANTXR2 VWA domain. Significant cross saturation (Is/Io#0.75) is indicated with a single asterisk, and highly
significant (Is/Io#0.5) is indicated with a double asterisk. For all graphs the errors were calculated by propagating the base-plane noise, which was
derived from the signal-to-noise ratios of both interleaved experiments. The data was taken from two separate experiments performed at pH 5.1 and
pH 5.15 and the average was derived from these experiments.
doi:10.1371/journal.ppat.1002354.g005
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PLoS Pathogens | www.plospathogens.org 9 December 2011 | Volume 7 | Issue 12 | e1002354Previous NMR studies had been interpreted as being consistent
with receptor release from the newly formed toxin pore. In
contrast to the current report, these studies included the detergent,
octyl-glucoside and a higher salt concentration in the samples, and
a lower temperature was used for the NMR experiments (293K
versus 310K). In one of these studies, strongest methyl resonance
of carbon-13 (SMRC) NMR analysis was employed, which
analyzes the first dimension of a
1H-
13C heteronuclear single
quantum coherence experiment (HSQC). That approach indicat-
ed that contacts between the PA pore and the ANTXR2 VWA-
domain were lost at acidic pH [25]. Similar experiments were
performed with a
13C-labeled 2 fluorohistidine labeled ANTXR2
VWA domain [25]. In both studies, a single peak was monitored
upon PA binding, the
1H methyl resonance of
13C labeled
ANTXR2 VWA domain, and was focused on the
1H methyl
resonance (0.8 ppm) in the presence or absence of PA63. In the
absence of PA63, a strong signal for the ANTXR2 VWA domain
was seen as a sharp peak at 0.8 ppm, but in the presence of the
toxin subunit, the peak signal was diminished because of line
broadening, and there was substantial loss of peak height due to
PA63 binding. These studies were conducted at both pH 8.0 and
5.0. Although the peak heights were increased at the lower pH
value indicating PA63 dissociation, they did not return to the levels
seen in the unbound state [25]. Therefore, we suggest that
receptor dissociation might not have been complete when these
studies were performed at pH 5.0. Consistent with the findings
reporting the present report, another NMR study performed by
the same group demonstrated that a recombinant fragment of PA
(PA domain 4) remained bound to the ANTXR2 VWA-domain at
pH 5.0 [27], although in that case it was not possible to relate
these effects to the process of prepore-to-pore conversion.
Previous co-immunoprecipitation experiments led to conflicting
conclusions about whether the receptor remains attached to the
newly formed anthrax toxin pore complex. In one study, a PA-
antiserum, that did not disrupt the PA63 prepore-receptor
interaction, was used to demonstrate that both ANTXR1 and
ANTXR2 co-precipitated with the PA63 prepore, but not with the
PA63 pore [23]. In another study, an antiserum that recognized an
epitope tag engineered into the cytoplasmic tail domains of both
receptors co-precipitated both PA63 prepore and pore complexes
[19,26]. In light of the current report, it seems most likely that the
latter study is correct and that these discrepant findings are
probably due to the PA antiserum disrupting the weakened PA63-
receptor interaction following pore formation. That effect would
not be seen with antibodies binding to the cytoplasmic tails of the
receptors. Therefore, these previous results obtained by co-
immunoprecipitation of membrane-associated proteins are consis-
tent with the conclusions of this report, i.e. both lines of evidence
support receptor-association following prepore-to-pore conversion.
The bound receptor might influence the structural and/or
functional integrity of the PA pore complex. The structure of the
PA pore resembles the mushroom shaped structure of S. aureus a-
Figure 6. Chemical shift changes of the ANTXR2 spectra due to PA binding at several pH values. A) Chemical shift changes are shown for
residues Y46, F47, G53, N57, the W59 indole, and G135, by comparing the unbound VWA domain at pH 8 (left panel) with the bound VWA-(PA63)7
complex at different pH values (right panels). N.D: Not Determined; Residue Y46 was not resolved at pH 5.1 B) Chemical shift perturbation of the
ANTXR2 VWA domain upon PA63 heptamer binding. Chemical shift perturbations were seen for residues Y46, F47, G53, N57, the W59 indole, and
G135 upon PA63 heptamer binding. These residues are modeled onto the crystal structure of the ANTXR2 VWA domain and highlighted in red.
doi:10.1371/journal.ppat.1002354.g006
Figure 7. Model of changes in the PA-receptor contacts that accompany toxin prepore-to-pore conversion. For clarity, only domains 2
and 4 of a single PA monomer are shown with the receptor. 1. The unbound receptor with the PA Domain 4 binding site highlighted in yellow to
indicate its ‘‘unbound’’ configuration. 2. The receptor binds to PA domains 2 and 4 forming a molecular clamp that blocks pore formation and
inducing a conformational change in PA domain 4 contact residues (indicated with cyan shading). 3. At pH 6 which is similar to the conditions in an
early endosomal compartment, the receptor contacts with PA domain 2 are weakened and PA domain 4 contact residues begin to revert back to their
‘‘unbound’’ configuration’’ (indicated with green shading). Additional allosteric effects are also detected at this pH value. 4. At ,pH 5 which is similar
to the conditions in a late endosomal compartment, PA domain 2 is no longer bound to receptor, presumably permitting movement of the 2b2-2b3
region of PA to mediate pore formation. The receptor remains bound to PA domain 4 after pore formation although certain PA domain 4 binding
residues of the receptor revert back to their ‘‘unbound’’ configuration (indicated with yellow shading). The bound receptor may stabilize the structure
and/or modify the function of the newly formed pore.
doi:10.1371/journal.ppat.1002354.g007
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are drastically different. Crystallographic studies of the a-
hemolysin pore revealed a mushroom structure with a 100 A ˚
diameter cap and a stem region of 52 A ˚ [44]. By contrast, electron
micrograph studies of the PA pore stabilized with GroEL revealed
a 125 A ˚ diameter cap and a stem region that was almost as long
(100 A ˚) [45]. Santelli and colleagues hypothesized that the
receptor might occupy the predicted 75 A ˚ gap between the pore
cap structure and the membrane, thereby stabilizing the pore [16].
The results of the present study, which demonstrates that receptor
remains bound to PA domain 4 after pore formation is triggered,
provide direct support for a possible pore-stabilizing role for the
receptor.
A pore-stabilizing role for the receptor is also consistent with
results from a previous voltage patch clamp study of ion
conductance by the PA pore in whole cells versus artificial
membranes. That study indicated that the receptor might
influence pore structure since it was associated with altered
voltage-dependent inactivation properties of the pore and with
altered sensitivity to inhibition by the small molecule inhibitor,
TBA [28]. Also consistent with such a role, it has been reported
that disulfide-bond formation in the extracellular immunoglobu-
lin-like region of ANTXR2, which lies between the membrane
and the VWA-domain of the receptor, can influence anthrax toxin
pore function [46]. Future studies will aim to uncover how the
receptor-PA domain 4 contacts influence the structure and or
function of the anthrax toxin pore.
Materials and Methods
Protein expression and purification
The VWA-domain of ANTXR2 (residues Ser38 to Cys218) was
produced from a pGEX-4T-1 vector (Amersham Pharmacia) and
was expressed as a GST fusion protein [47] in Escherichia coli C43
(DE3) cells (OverExpress). The RIL plasmid of BL21-CodonPlus-
RIL cells (Stratagene) was also co-expressed in the C43 (DE3) cells









2H ANTXR2 VWA-domain samples were prepared for
NMR studies from 4 liters of E. coli culture grown in standard M9
minimal media with
15NH4Cl at 0.1% (wt/vol), with and without
13C6-glucose or
2H/
13C-glucose (0.4% (wt/vol). Unlabeled
samples of the ANTXR2 VWA-domain were produced in
standard Terrific Broth. The cell cultures were grown with
carbenicillin (50 ug/ml), chloramphenicol (34 ug/ml), and specti-
nomycin (50 ug/ml) for plasmid selection.
For the transfer cross saturation (TCS) experiments, the
ANTXR2 VWA-domain was produced in 100% D2O based M9
minimal media supplemented with
15NH4Cl (0.1% wt/vol),
2H/
13C6-glucose (0.4% wt/vol) and MEM Vitamin B solution
(Sigma). Growth of the C43 (DE3) cells in 100% D2O required
acclimating the cells in 5 mls of standard M9 minimal media and
slowly acclimating the cells to a 20% increase in D2O levels every
12–24 hours until growth was sustained in 100% D2O-containing
medium. A 5 ml sample of cells grown in 100% M9 media was
then used to inoculate 1L of 100% D2O M9 media, which was
then used for standard isotopic labeling procedures. Once the cell
populations had reached an OD600 of 0.75, ANTXR2 VWA-
domain expression was induced with 0.5 mM isopropyl b-d-
thiogalactopyranoside (IPTG) for 6–8 hours at 37uC. The
bacterial cells were then harvested by centrifugation at 80006 g
in a JA-10 rotor and resuspended into 50–75 ml of lysis buffer
(50 mM Tris pH 7.5; 150 mM NaCl; 1 mg/ml lysozyme, 100
units DNAse). The cells were then lysed by three cycles of
sonication (0.5 sec pulses/20 seconds per cycle using a 550 Sonic
Dismembrator (Fisher Scientific)) and protease inhibitor cocktail II
tablets (Roche) were added to the lysate. The lysate was cleared by
centrifugation at 12,0006g in a JA-20 rotor for 1 hour at 4uC and
the supernatant was filtered with a 45 mm filter (vacuum filtration
device (Nalgene)). The supernatant was circulated over a 5 ml
GSTrap HiTrap FF column (Amersham Pharmacia) using a
peristaltic pump (LKB Pump P1, Amersham Pharmacia). The
resin was then washed with Buffer A (50 mM Tris HCl pH 8.0;
150 mM NaCl) and incubated with 5 mls of thrombin cleavage
buffer (50 mM Tris HCl pH 8.0; 150 mM; 5 mM CaCl2; 500
units thrombin (Sigma)) for 12–16 hours overnight at room
temperature. The labeled protein samples were eluted with Buffer
A and cleared of thrombin using a HiTrap Benzamidine FF
column (Amersham Pharmacia). The protein was further concen-
trated using a filtered centrifugal device (Vivaspin 15R, Sartorius).
A lack of several backbone amide resonances in the [
15N,
1H]
TROSY-HSQC of the ANTXR2 VWA-domain was observed
and attributed to slow back exchange of the amides from
deuterons to protons, when the protein expressing E. coli were
grown in a D2O based media. Because this phenomenon resulted
in the loss of several probes, the deuterium-labeled ANTXR2
VWA-domain had to be unfolded to protonate the deuterated
residues that were buried within the core of the folded protein.
ANTXR2 VWA-domain was unfolded at a concentration of
1 mg/ml and protein unfolding was performed for 1 hour at 4uC
in unfolding buffer (3M guanidine HCl; 50 mM Tris-HCl pH 8.0;
150 mM NaCl). It was then added drop-wise with stirring into
refolding buffer (50 mM Tris-HCl; 2 mM MgCl2; 150 mM NaCl;
10% vol/vol glycerol) at 4uC, and kept under agitation for one
hour. The refolded protein sample was then dialyzed against
NMR buffer (50 mM Tris-HCl pH 8.0; 150 mM NaCl) and
concentrated using a filtered centrifugal device (Vivaspin 15R,
Sartorius). The integrity of the refolded protein was demonstrated
by a [
15N,
1H] TROSY-HSQC which was comparable to a control
spectrum of a non-denatured
1H-
15N ANTXR2 VWA-domain,
and through an in vitro toxin neutralization assay as described
elsewhere [48].
PA83 was expressed from a pET22b
+ vector (Novagen) [49] in
Rosetta 2 cells (Novagen) due to rare codon usage and grown at
37uC in Luria Broth containing carbenicillin (50 ug/ml) and
chloramphenicol (34 ug/ml). Cells were grown to an OD600 of
1.0, and PA83 expression was induced by addition of 0.5 mM
IPTG for 6 h at 25uC. Periplasmic proteins were obtained by
osmotic shock by first resuspending pelleted cells in 1L of Buffer B
(20% sucrose; 5 mM EDTA; 50 mM Tris-HCl (pH 8.0)) with
stirring at room temperature for ten minutes. The cells were then
harvested at 80006g for 15 minutes at 4uC in a JA-10 rotor and
the pellet was resuspended with stirring in a cold 5 mM MgSO4
solution at 4uC for 15 minutes. This sample was centrifuged again
with the same harvesting conditions, protease inhibitor tablets
(Roche) were added and the resulting supernatant containing the
desired protein was brought up to 50 mM Tris HCl at pH 8.0
with a 1M stock solution of Tris HCl pH 8.0. The supernatant was
then circulated over an anion-exchange HiTrap QFF column
(Amersham Pharmacia) and purified with a gradient of 0M to 1M
NaCl in buffer A (50 mM Tris-HCl; pH 8.0) using an AKTA-
FPLC system (Amersham Pharmacia). Column fractions contain-
ing PA83 were then concentrated and applied to a Hi Load
Superdex 26/60 gel filtration column (Amersham Pharmacia) and
eluted using gel filtration buffer (50 mM Tris-HCl; 150 mM NaCl;
pH 8.0). PA83 was purified to 90% homogeneity, as judged by a
Coomassie stained SDS-PAGE gel and concentrated using
centrifugal filter devices (Vivaspin 15R, Sartorius). This protocol
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scale prep for NMR studies [49].
To generate PA63 by trypsin cleavage [49], the purified PA83
sample was concentrated down to 1.5 ml (final concentration
5 mg/ml) for treatment with trypsin-conjugated magnetic beads.
Prior to that incubation, 1 ml of the magnetic beads slurry (Mag-
Trypsin, Clontech) was washed in gel filtration buffer and then
separated from the wash using a microfuge magnetic stand
(Promega). The washed beads were then mixed with the purified
PA83 for 45 minutes at room temperature with constant agitation
(Nutator). The trypsin beads were then removed using the
magnetic stand and the generated PA63 heptamer was purified
by gel filtration using a Hi Load Superdex 26/60 gel filtration
column (Amersham Pharmacia) and samples were eluted with gel
filtration buffer (50 mM Tris-HCl; 150 mM NaCl; pH 8.0).
Fractions containing the heptamer were then concentrated by a
filtered centrifugal device (Vivaspin 15R, Sartorius). The compo-
sition of the PA63 heptamer was confirmed by static light
scattering/refractive index measurements coupled with size
exclusion chromatography (data not shown).
Circular Dichroism spectroscopy of ANTXR2
The ANTXR2 VWA-domain was purified as described, and the
samples were concentrated to 10 mg/mL and stored at 4uC. The
concentrated samples were diluted into either Buffer A (50 mM
Tris-HCl, pH 8.0; 5 mM DTT, 150 mM NaCl, 2.5 mM MgCl2)
or into Buffer B (50 mM sodium phosphate buffer, pH 5.0 or 6.0;
150 mM NaCl; 2.5 mM MgCl2) to a final concentration of
25 mM, Supplementary Figures S1 and S2, respectively. The
solution was then placed into a 0.1-cm path-length quartz cell
(Hellma, Forest Hills, NY). Spectra were acquired using a
BioLogic MOS-450 (Molecular Kinetics, Pullman, WA). All
measurements were done at 25uC. Spectra were recorded at a
wavelength range of 190–260 nm. Three independent experi-
ments were performed with each sample. Raw data were
manipulated by smoothing and subtraction of buffer spectra,
according to the manufacturer’s instructions.
Assessment of in vitro aggregation
300 mM of ANTXR2 VWA domain was incubated at 37uC for
48 hours in buffers ranging from pH 8, 7, 6, and 5. Buffer A
(50 mM Tris-HCl, 150 mM NaCl, 2.5 mM MgCl2) was used for
the pH 8 and pH 7 samples. Buffer B (50 mM phosphate buffer;
150 mM NaCl, 2.5 mM MgCl2) was used for and the pH 6 and
pH 5.1 samples. The samples were subjected to a wavelength scan
using a Beckman DU 530 Life Science UV/VIS spectrophotom-
eter. The apparent optical density, which is proportional to
turbidity, was then analyzed at 340 nm.
Assignment of the ANTXR2 VWA-domain
All NMR experiments were recorded at 310K on a Bruker 700-
MHz spectrometer equipped with four radiofrequency channels
and a triple-resonance cryoprobe with a shielded z-gradient coil.






2H, 350 mM labeled ANTXR2 VWA-domain in NMR
buffer (50 mM Tris-HCl (pH 8.0); 150 mM NaCl; 0.01% NaN3;
10/90 D2O/H2O), if not stated otherwise. Assignments for the
backbone resonances were obtained using data from the following
experiments: [
1H,
15N] TROSY-HSQC, 3D TROSY-HNCO, 3D
TROSY-HN(CA)CO, 3D TROSY-HNCACB, 3D TROSY-
HNCA, and a 3D
15N-edited NOESY-HSQC. NMR data were
processed using NMRPipe and analyzed using the Sparky and
CARA software packages [34,35].
Transferred cross saturation experiments
Transferred cross-saturation experiments were performed with
deuterated,
15N-labeled ANTXR2 VWA-domain in a buffer
containing 85-90% D2O. The final NMR sample contained
350 mM VWA-domain and 35 mMP A 63 (ratio 10:1) in NMR
buffer (50 mM deuterated Tris-HCl pH 8.0 buffer; 5 mM DTT;
150 mM NaCl; 2.5 mM MgCl2; 85% D2O/H2O) or low pH
NMR buffer (50 mM sodium phosphate buffer pH 6.0 or 5.1;
150 mM NaCl; 2.5 mM MgCl2; 85% D2O) Experiments were
performed at 310K. Selective saturation of the protein was
achieved by applying a train of Gaussian shaped pulses prior to the
[
1H-
15N] TROSY-HSQC experiment with the saturation fre-
quency set to 0.8 ppm [32,50]. The experiment was performed in
an interleaved manner with a phase sensitive Echo/Antiecho
gradient selection. Experiments were performed similarly with 120
scans, 0.5 sec saturation durations, and a relaxation delay of 2.0 s.
The experiments were performed with 20486256 complex points
in the
1H and
15N dimensions with spectral widths of 10000 and
2270 Hz, respectively. The spectra were transformed to 20486
256 complex points using zero-filling.
Supporting Information
Figure S1 Far-UV CD spectrum of the refolded ANTXR2
VWA-domain in A) 50 mM Tris-HCl buffer, pH 8.0, B) 50 mM
sodium phosphate buffer, pH 6.0, and C) 50 mM sodium
phosphate buffer, pH 5.0
(TIF)
Figure S2 The refolded, double-labeled ANTXR2 VWA-
domain acts as an efficient receptor decoy that protects
RAW264.7 cells against intoxication by anthrax lethal toxin.
(TIF)
Figure S3 Selected cross-sections of the HNCACB showing
connectivity between several backbone residues of the ANTXR2
VWA-domain. Additional spectra were also obtained for back-
bone assignment.
(TIF)
Figure S4 PA63 heptamer forms a SDS-resistant species that is
consistent with the pore in the presence of ANTXR2 VWA-
domain at an acidic pH of ,5.2. PA63 at 15 mM was incubated
with 150 mM ANTXR2 VWA domain overnight at 37uC at the
various pH values shown. The samples were then subjected to
SDS-PAGE. As shown, in the presence of ANTXR2 VWA
domain, the SDS resistant PA63 heptameric pore was formed only
at pH,5.2.
(TIF)
Table S1 Turbidity of the ANTXR2:PA complex at a 10:1
ratio. A sample containing 200 mM ANTXR2 and 20 mM
(PA63)7 was incubated at 37uC and either pH 8.0 or pH 5.1 for 24
hours and the absorbance values at 340 nm were measured.
(TIF)
Table S2 Protein absorbance of ANTXR2:PA after 24 hours
incubation at 37uC. A 250 mL sample containing 200 mM
ANTXR2 and 20 mM (PA63)7 was incubated at 37uC and either
pH 8.0 or pH 5.1 for 24 hours. The samples were then
centrifuged using a table top centrifuge (Eppendorf Centrifuge
5424) at 13,000 rpm for 1 minute and the protein concentrations
in the supernatants were measured at A280 nm. SDS-PAGE
analysis was used to confirm that the PA heptamer remained in
solution (data not shown).
(TIF)
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